To evaluate the impact of clinical pharmacist-led discharge education service in patients with acute coronary syndrome.
This prospective, randomized controlled study was conducted in patients with acute coronary syndrome in an cardiology service of tertiary training and research hospital. The clinical pharmacist, within the scope of the discharge education services, provided medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally \[by using Teach back method especially for patients with low health literacy\]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model). The control group received standard care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
177
medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally \[by using Teach back method especially for patients with low health literacy\]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model).
Marmara University
Istanbul, Turkey (Türkiye)
30 days hospital re-admission for cardiac reasons
Proportion of patients readmitted to hospital for cardiac cause at 1 month
Time frame: 30 days
Hospital re-admission for cardiac reasons
Proportion of patients readmitted to hospital for cardiac cause through 1 year.
Time frame: 3 months, 6 months, and 12 months
Hospital re-admission for any reasons
Proportion of patients readmitted to hospital for any cause through 1 year.
Time frame: 1 month, 3 months, 6 months, and 12 months
Emergency service visits
Proportion of patients visited to emergency service through 1 year.
Time frame: 1 month, 3 months, 6 months, and 12 months
Major Adverse Cardiovascular Event
Proportion of patients had major adverse cardiovascular event through 1 year.
Time frame: 1 month, 3 months, 6 months, and 12 months
Death for cardiac reason
Proportion of patients died for cardiac cause through 1 year.
Time frame: 1 month, 3 months, 6 months, and 12 months
Death for any reason
Proportion of patients dying for any cause through 1 year.
Time frame: 1 month, 3 months, 6 months, and 12 months
Medication Adherence
Adherence to Cardioprotective Medications (Clopidogrel, Statins, Beta-blockers, Angiotensin-converting enzyme (ACE) inhibitors/ Angiotensin receptor blocker (ARB) through 1 year assessed by Medication Adherence Report Scale (MARS). MARS assesses adherence through 5-item, summed to give a scale score ranging from 5 to 25, where higher scores indicate higher levels of reported adherence.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 1 month, 3 months, 6 months, and 12 months
Quality of Life Measurement
Change in quality of life from baseline assessed with EuroQol questionnaire EQ-5D-3L through 1 year. (EQ-5D-3L) is a standardized scale for use as a measure of the quality of life. The EQ-5D-3L descriptive system comprises the following 5 dimensions (5D): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 3 levels (3L): no problems (1 point), some problems (2 points), extreme problems (3 points). This gives a total of 245 different health states, adding unconscious and dead.
Time frame: 1 month, 3 months, 6 months, and 12 months
Achieved Target Low-density Lipoprotein Value
Rate of patients achieved target low-density lipoprotein value
Time frame: 6 months, 12 months